{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:58:01Z","timestamp":1784807881712,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000},"content-version":"vor","delay-in-days":378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jacc.2018.05.058","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T14:11:16Z","timestamp":1533564676000},"page":"721-733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation"],"prefix":"10.1016","volume":"72","author":[{"given":"John D.","family":"Horowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamila","family":"Heresztyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato D.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe Gabriel","family":"Steg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine M.","family":"Hylek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Jansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Granger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Wallentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2018.05.058_bib1","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.05.058_bib2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2018.05.058_bib3","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1161\/01.CIR.0000033220.97592.9A","article-title":"Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors","volume":"106","author":"Conway","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.05.058_bib4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1253\/circj.66.583","article-title":"Impaired exercise-induced vasodilatation in chronic atrial fibrillation\u2013role of endothelium-derived nitric oxide","volume":"66","author":"Takahashi","year":"2002","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2018.05.058_bib5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nm.2124","article-title":"Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation","volume":"16","author":"Rudolph","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2018.05.058_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2018.05.058_bib7","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/STROKEAHA.110.609297","article-title":"Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring","volume":"42","author":"Boriani","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2018.05.058_bib8","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A\u00a0novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2018.05.058_bib9","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.111.060541","article-title":"Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase","volume":"124","author":"von Leitner","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.05.058_bib10","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.metabol.2010.04.012","article-title":"Plasma myeloperoxidase is inversely associated with endothelium-dependent vasodilation in elderly subjects with abnormal glucose metabolism","volume":"59","author":"van der Zwan","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/j.jacc.2018.05.058_bib11","first-page":"2842S","article-title":"Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the \u201cL-arginine paradox\u201d and acts as a novel cardiovascular risk factor","volume":"134 Suppl","author":"Boger","year":"2004","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.jacc.2018.05.058_bib12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijcard.2014.10.137","article-title":"Impaired platelet nitric oxide response in patients with new onset atrial fibrillation","volume":"179","author":"Procter","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2018.05.058_bib13","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.hrthm.2015.12.010","article-title":"New-onset atrial fibrillation and thromboembolic risk: cardiovascular syzygy?","volume":"13","author":"Procter","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2018.05.058_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00059-015-4335-y","article-title":"Platelet hyperaggregability in patients with atrial fibrillation: evidence of a background proinflammatory milieu","volume":"41","author":"Procter","year":"2016","journal-title":"Herz"},{"key":"10.1016\/j.jacc.2018.05.058_bib15","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1177\/1358836X0501000103","article-title":"ADMA: its role in vascular disease","volume":"Suppl 1","author":"Cooke","year":"2005","journal-title":"Vasc Med"},{"key":"10.1016\/j.jacc.2018.05.058_bib16","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/01.CIR.0000126823.07732.D5","article-title":"Asymmetrical dimethylarginine: the Uber marker?","volume":"109","author":"Cooke","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.05.058_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.phrs.2009.07.001","article-title":"Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality\u2013an update on patient populations with a wide range of cardiovascular risk","volume":"60","author":"Boger","year":"2009","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jacc.2018.05.058_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrneph.2011.31","article-title":"The role of asymmetric and symmetric dimethylarginines in renal disease","volume":"7","author":"Schwedhelm","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jacc.2018.05.058_bib19","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1681\/ASN.2005101119","article-title":"Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease","volume":"17","author":"Bode-Boger","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2018.05.058_bib20","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2018.05.058_bib21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ahj.2009.07.035","article-title":"Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale","volume":"159","author":"Lopes","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2018.05.058_bib22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jchromb.2004.03.020","article-title":"Determination of l-arginine and NG, NG- and NG, G'-dimethyl-L-arginine in plasma by liquid chromatography as AccQ-Fluor fluorescent derivatives","volume":"805","author":"Heresztyn","year":"2004","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jacc.2018.05.058_bib23","first-page":"87","article-title":"Endothelial dysfunction in atherosclerosis","volume":"89 Suppl 1","author":"Harrison","year":"1994","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jacc.2018.05.058_bib24","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ijcard.2015.05.102","article-title":"ADMA, subclinical changes and atrial fibrillation in the general population","volume":"203","author":"Ramuschkat","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2018.05.058_bib25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/1479164110366053","article-title":"Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus","volume":"7","author":"Anderssohn","year":"2010","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.jacc.2018.05.058_bib26","first-page":"26","article-title":"Apparently \u201clow\u201d serum asymmetric dimethylarginine is associated with fasting glucose and tends toward association with type-2 diabetes","volume":"14","author":"Onat","year":"2014","journal-title":"Anadolu Kardiyol Derg"},{"key":"10.1016\/j.jacc.2018.05.058_bib27","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1161\/CIRCULATIONAHA.107.690016","article-title":"Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young Finns study","volume":"116","author":"Juonala","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.05.058_bib28","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.CIR.98.18.1842","article-title":"Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in\u00a0hypercholesterolemia","volume":"98","author":"Boger","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2018.05.058_bib29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/10715762.2010.527337","article-title":"Piceatannol is more effective than resveratrol in restoring endothelial cell dimethylarginine dimethylaminohydrolase expression and activity after high-glucose oxidative stress","volume":"45","author":"Frombaum","year":"2011","journal-title":"Free Radic Res"},{"key":"10.1016\/j.jacc.2018.05.058_bib30","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/eurheartj\/ehp061","article-title":"Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis","volume":"30","author":"Antoniades","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2018.05.058_bib31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jchromb.2006.09.023","article-title":"An overview of plasma concentrations of asymmetric dimethylarginine (ADMA) in health and disease and in clinical studies: methodological considerations","volume":"851","author":"Horowitz","year":"2007","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jacc.2018.05.058_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/CS20110013","article-title":"Symmetric dimethylarginine is a marker of detrimental outcome in the acute phase after ischaemic stroke: role of renal function","volume":"122","author":"Luneburg","year":"2012","journal-title":"Clin Sci"},{"key":"10.1016\/j.jacc.2018.05.058_bib33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.atherosclerosis.2009.06.039","article-title":"Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke","volume":"208","author":"Schulze","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2018.05.058_bib34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00392-012-0515-4","article-title":"Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study","volume":"102","author":"Siegerink","year":"2013","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacc.2018.05.058_bib35","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1161\/ATVBAHA.113.301219","article-title":"Symmetrical dimethylarginine predicts mortality in the general population: observations from the Dallas heart study","volume":"33","author":"Gore","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2018.05.058_bib36","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/ndt\/gfs554","article-title":"Effects of chronic SDMA infusion on glomerular filtration rate, blood pressure, myocardial function and renal histology in C57BL6\/J mice","volume":"28","author":"Veldink","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2018.05.058_bib37","doi-asserted-by":"crossref","first-page":"413826","DOI":"10.1155\/2013\/413826","article-title":"Regulation and prognostic relevance of symmetric dimethylarginine serum concentrations in critical illness and sepsis","volume":"2013","author":"Koch","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jacc.2018.05.058_bib38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000322614","article-title":"Symmetrical dimethylarginine outperforms CKD-EPI and MDRD-derived eGFR for the assessment of renal function in patients with adult congenital heart disease","volume":"34","author":"Tutarel","year":"2011","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.jacc.2018.05.058_bib39","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.2215\/CJN.01720211","article-title":"Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease","volume":"6","author":"Schepers","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2018.05.058_bib40","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1155\/2013\/306908","article-title":"Assessment of endothelial dysfunction: the role of symmetrical dimethylarginine and proinflammatory markers in chronic kidney disease and renal transplant recipients","volume":"35","author":"Memon","year":"2013","journal-title":"Dis Markers"},{"key":"10.1016\/j.jacc.2018.05.058_bib41","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/eurheartj\/ehw054","article-title":"The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation","volume":"37","author":"Hijazi","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2018.05.058_bib42","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/S0140-6736(16)00741-8","article-title":"The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study","volume":"387","author":"Hijazi","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2018.05.058_bib43","doi-asserted-by":"crossref","first-page":"7521","DOI":"10.3390\/ijms13067521","article-title":"Mechanism of cellular oxidation stress induced by asymmetric dimethylarginine","volume":"13","author":"Mohan","year":"2012","journal-title":"Int J Mol Sci"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109718351970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109718351970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:16:02Z","timestamp":1760015762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109718351970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0735109718351970"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2018.05.058","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2018.05.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier on behalf of the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}